Bidding for the initial public offering (IPO) of Dr Agarwal's Health Care Limited opened on 29 January 2025 and will remain ...

Zee Business Managing Editor Anil Singhvi advises that only high-risk investors should consider subscribing to Dr. Agarwal’s Health Care IPO.

Ascentage is looking to use the IPO proceeds to advance its Phase III candidates for chronic or small lymphocytic leukemia ...

Denta Water and Infra IPO allotment status comes ahead of its listing on BSE and NSE later this week. The current grey market ...

As per media reports, the reason behind the delay for finalizing allotment status was because of high number of subscription ...

The offering is oversubscribed 32.06 times, with significant interest from retail and non-institutional investors.

According to market observers, shares of the company are available at a premium of ₹151 in the grey market today ...